Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    Advanced Search
    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Canadian Federal Government
        • Canadian Municipal Government
        • Canadian Provincial Government
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Advanced Search
    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • IR
    • All Products
    • Become a Client
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • General Enquiries
    • Media
    • Worldwide Offices
    • Hamburger menu
    • Cision Canada
    • Send a Release
    • FR
      • Phone

      • 877-269-7890 from 8 AM - 10 PM ET

      • ALL CONTACT INFO
      • Contact Cision

        877-269-7890
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • 3 News in Focus
      • 5 Business
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • IR
      • All Products
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      • Become a Client
      • Request a Demo
      • Editorial Bureaus
      • Partnerships
      • General Enquiries
      • Media
      • Worldwide Offices
      • General Enquiries
      • Send a Release
      • Sign Up
      • Resources
      • Investor Relations
      • Journalists
      • Webcasts
      • my CNW
      • GDPR
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business) Business
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Dialogue Health Technologies Reports First Quarter 2022 Results

      Dialogue Logo (CNW Group/Dialogue Health Technologies Inc.)

      News provided by

      Dialogue Health Technologies Inc.

      May 09, 2022, 16:30 ET

      Share this article

      Share this article


      Landmark contract for our EAP, $90 million in ARR, and member count in excess of 2 million highlight another strong quarterly performance

      MONTREAL, May 9, 2022 /CNW Telbec/ - Dialogue Health Technologies Inc. (TSX: CARE) ("Dialogue" or the "Company"), Canada's premier health and wellness virtual healthcare platform, announced today its financial and operational results for the three months and three months ended March 31, 2022. Financial references are in Canadian dollars unless otherwise indicated.

      "The team is executing very well on our growth strategy, building a robust and unparalleled integrated health platform that is resonating deeply with customers," said Cherif Habib, Chief Executive Officer of Dialogue. "In the first quarter, we continued to gain market share with our virtual EAP and signed more than 60% of our new customers to multiple services. With the recent acquisition of Tictrac, we are adding a wellness component to our platform that will allow us to engage members more frequently throughout their journey to better health and well-being. As in years past, 2022 is shaping up to be our most exciting one yet."

      Navaid Mansuri, Chief Financial Officer, added: "We exceeded two million members during the quarter and ended the period with more than $90 million in ARR. On the heels of many large customer wins in the last two quarters, we invested in our operations to ensure that we can successfully support our customers with best-in-class service, as we always have. We are well positioned for growth ahead and expect that our margins and operating leverage will continue to improve in the coming quarters, putting us well on track to achieve our profitability objectives in the second half of 2023."

      Q1 2022 Financial Highlights
      (All capitalized terms not defined herein, shall have the meaning and usefulness ascribed to them in the Management's Discussion and Analysis for the three months ended March 31, 2022. Comparison periods in each case are the three months ended March 31, 2021, unless otherwise stated.)

      • Annual Recurring and Reoccurring Revenue ("ARR") grew 38.4% year-over-year to $90.3 million, driven by new Customer wins. In addition to our previously announced agreement with Scotiabank, these wins also include a leading retailer of optical products, a large healthcare consulting services firm, a multinational computer software technology corporation, and a digital media and internet company. We also saw several important program expansions and the addition of new services by existing Customers, including a large video game company and a global provider of e-commerce software.
      • Revenue in the first quarter of 2022 increased by 35.8% year-over-year to $20.7 million, due to growth in Members, both Direct and from agreements with strategic distribution partners, and an increase in the Attach Rate as existing Customers add more services over time.
      • Members grew to more than 2.0 million, an increase of nearly 800,000, or 61.4%, year-over-year, and approximately 200,000, or 10.7%, compared to the fourth quarter of 2021.
      • Attach Rate grew to 1.51 from 1.08 in the first quarter last year, mainly due to the addition of our internet-based cognitive and behavioural therapy ("iCBT") to Canada Life's Consult+ platform.
      • Member-Service Units, which we define as total Members multiplied by the Attach Rate, rose 125.6% year-over-year to just under 3.1 million from approximately 2.0 million in the first quarter last year. This meaningful increase demonstrates the success of Dialogue's land and expand strategy, as both existing and new Customers continue to leverage our Integrated Health PlatformTM.
      • 61% of new direct Members signed up for two services or more in the first quarter of 2022. Combined with current Customer expansions, the cumulative number of direct Members with two or more services was 22% at the end of the first quarter of 2022, compared to 16% at the same time last year and 21% at the end of the fourth quarter of 2021.
      • Average Monthly Net Retention Rate ("NRR") was 101% for the first quarter of 2022, marking another quarter of NRR greater than 100%. During the period, we experienced a low churn of approximately 0.24%, or 4,400 members, within our mid-market and enterprise customer categories. Furthermore, we communicated and successfully implemented pricing increases to many customers whose contracts were renewing at the start of the year.
      • Gross Margin increased to 42.3%, compared to 41.5% in the first quarter of 2021, as we realized efficiencies in our operations, mainly due to the continued scaling of our Mental Health service and Employee Assistance Program ("EAP") as well as to the migration of Optima Customers to our Dialogue EAP. This was offset in part by the timing of investments to support the planned onboarding of several large customers in the second quarter of 2022, prior to the recognition of revenue from those customers.
      • Adjusted EBITDA1 loss was $5.7 million, compared to a loss of $5.0 million in the same period last year. The increase was due mainly to a planned increase in operating expenses year-over-year to support our growth, to launch and promote new services, to develop our technology platform, and to sustain a public company structure, partially offset by higher gross profit.
      • Net loss was $7.1 million, compared to $231.2 million in the same period last year. The decrease was primarily due to the accounting charge in the first quarter of 2021 related to the increase in the fair market value conversion feature of the Class B preferred shares as well as an increase in operating expenses, partially offset by higher gross profit.
      • Cash and Cash Equivalents were $96.0 million as of March 31, 2022, compared to $104.3 million as of December 31, 2021. The decrease was the result of cash used in operations during the quarter.

      ______________________________

      1 Adjusted EBITDA is a Non-IFRS financial measure. Refer to the reconciliation contained in the Non-IFRS Financial Measures section, beginning on page 3 of this earnings release.

      Q1 2022 Business Highlights and Subsequent Events

      • On January 11, 2022, we published our 2nd annual Canadian Attitudes on Health and Virtual Care Report, a joint study with Environics Research. Key findings provide strong evidence that working Canadians support the provision of virtual care services through their benefit plans.
      • On February 22, 2022, we announced an agreement to offer our virtual EAP to more than 38,000 employees at Scotiabank, beginning on April 1, 2022. This represented our largest direct customer win to date for that service.
      • On March 17, 2022, we published a report that we co-sponsored with Sun Life, which analyzed the economic impact of telemedicine on Canada's healthcare system. The Economic Impact of Telemedicine in Canada report, compiled by AppEco, estimates that governments across Canada could save up to $1 billion per year by 2025 with the adoption of telemedicine platforms.
      • Subsequent to quarter end, on April 13, 2022, we acquired London, UK-based Tictrac Ltd. for up to $56 million (£35 million), subject to certain earn-out conditions. Tictrac is a SaaS-based provider of a global health and wellness platform that enables healthier living for everyone. The transaction was closed successfully on April 30, 2022.
      • Subsequent to quarter end, on April 21, 2022, we launched Mental Health+, building on the success of our stress management and well-being service and iCBT. This comprehensive offering will be available to all new clients and to existing clients who wish to transition from their existing program.
      • We have been recognized by Great Place to Work® in the Best WorkplacesTM for Women Canada 2022 category.

      Upcoming events

      • Roth Canada Corporate Access Day in New York City on May 17, 2022.
      • RBC Capital Markets 2022 Global Healthcare Conference in New York City on May 18, 2022.
      • CIBC Capital Markets Technology and Innovation Conference 10.0 in Toronto on May 26, 2022.
      • National Bank Financial 12th Annual Quebec Conference in Toronto on June 9, 2022.

      Notice of Conference Call

      Dialogue will host a live video webinar on Tuesday, May 10, 2022 at 9:00 a.m. ET to discuss its financial results. Cherif Habib, CEO, and Navaid Mansuri, CFO, will co-chair the call. All interested parties can join the event at the following link, which is also available in the Events and Presentations section of the Company's website. The presentation will be accompanied by slides, which will be available on the screen view and will be made available prior to the start of the webinar on  the Company's website. Please connect at least 15 minutes prior to the event to ensure adequate time for any software download of Zoom that may be required to attend the event. Listeners that prefer to dial in by phone may do so by accessing the same web link and the dial in details will be provided by email upon registration.

      Non-International Financial Reporting Standards ("IFRS") Financial Measures

      This press release makes reference to certain non-IFRS measures, such as "EBIT" represents net profit or loss before net financing (income) expenses and income taxes,  "EBITDA" (which stands for net profit or loss before net financing (income) expenses, income taxes, depreciation of property and equipment, amortization of intangible assets, and amortization of right-of-use assets) and "Adjusted EBITDA" (which stands for net profit or loss before net financing (income) expenses, income taxes, depreciation of property and equipment, amortization of intangible assets, amortization of right-of-use assets, transaction costs, acquisition costs, change in fair value of conversion feature, share-based payments expense, change in fair value of contingent consideration, severance costs, and foreign exchange gain or loss). These measures are not recognized under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management's perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information as reported under IFRS. Management also believes that other users, such as securities analysts, investors and other interested parties, frequently use non-IFRS measures, particularly in the evaluation of issuers.

      Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts and to determine components of management compensation. Where applicable, we provide a clear quantitative reconciliation from the non-IFRS financial measures to the most directly comparable measure calculated in accordance with IFRS.

      The following table reconciles net loss to Adjusted EBITDA loss for the three months ended March 31, 2022 and 2021:

      DIALOGUE HEALTH TECHNOLOGIES INC.
      ADJUSTED EBITDA
      FOR THE THREE MONTHS ENDED MARCH 31, 2022 and 2021

      (in thousands of CAD)


      Three months ended
      March 31,



      2022


      2021



      $


      $






      Net loss


      (7,068)


      (231,235)

      Net financing (income) expenses


      (25)


      188

      Current income tax expense


      —


      —

      Deferred income tax recovery


      (85)


      (105)

      EBIT


      (7,178)


      (231,152)

      Depreciation of property and equipment


      148


      109

      Amortization of intangible assets


      402


      330

      Amortization of right-of-use assets


      150


      148

      EBITDA


      (6,478)


      (230,565)

      Share-based payments expense


      568


      97

      Acquisition costs


      94


      43

      Change in fair value of conversion feature


      —


      225,417

      Change in fair value of contingent consideration


      91


      —

      Adjusted EBITDA


      (5,725)


      (5,008)

      About Dialogue
      Incorporated in 2016, Dialogue is Canada's premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. Through our team of health professionals, we serve employers and organizations who have an interest in the health and well-being of their employees, members and their families. Our Integrated Health Platform™ is a one-stop healthcare hub that centralizes all of our programs in a single, user-friendly application, providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet.

      Forward-Looking Information

      This release includes "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking information may relate to our financial outlook (including revenues and Adjusted EBITDA), and anticipated events or results and may include information regarding our financial position, business strategy, growth strategies, addressable markets, budgets, operations, financial results, taxes, dividend policy, plans and objectives.

      In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward-looking terminology such as "plans" "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management's current beliefs, expectations, estimates and projections regarding future events and operating performance.

      Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Dialogue as of the date of this release, are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ, possibly materially, from those indicated by the forward-looking statements include, but are not limited to, the risk factors identified under "Risk Factors" in the Company's latest annual information form, and in other periodic filings that the Company has made and may make in the future with the securities commissions or similar regulatory authorities in Canada, all of which are available under the Company's SEDAR profile at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect Dialogue. However, such risk factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. Dialogue undertakes no obligation to publicly update any forward-looking statement, except as required by applicable securities laws.

      Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not currently known to us or that we currently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, you should not place undue reliance on forward-looking information. The forward-looking information represents our expectations as of the date of this earnings release (or as the date it is otherwise stated to be made) and is subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable Canadian securities laws. All of the forward-looking information contained in this earnings release is expressly qualified by the foregoing cautionary statements.

      DIALOGUE HEALTH TECHNOLOGIES INC.
      INTERIM CONDENSED CONSOLIDATED STATEMENT OF NET LOSS AND OTHER COMPREHENSIVE INCOME
      FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021

      (in thousands of CAD except share and per share data)


      Three months ended
      March 31,



      2022


      2021



      $


      $






      Revenue


      20,686


      15,238

      Cost of services


      11,926


      8,908

      Gross profit


      8,760


      6,330






      Operating expenses





      General and administrative


      9,445


      7,583

      Sales and marketing


      3,227


      2,398

      Product and development


      2,675


      1,987

      Share-based payments expense


      568


      97



      15,915


      12,065






      Operating loss


      (7,155)


      (5,735)






      Other expenses





      Change in fair value of conversion feature


      —


      225,417

      Net financing (income) expenses


      (25)


      188



      (25)


      225,605






      Net loss before income taxes


      (7,130)


      (231,340)

      Current income tax (expense)


      (23)


      —

      Deferred income tax recovery


      85


      (105)

      Net loss


      (7,068)


      (231,235)











      Other comprehensive income










      Items that may be reclassified subsequently to net loss





      Foreign currency translation gain


      360


      311






      Total comprehensive loss


      (6,708)


      (230,924)






      Loss per share - basic and diluted


      (0.11)


      (3.55)

      DIALOGUE HEALTH TECHNOLOGIES INC.
      INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
      AS AT MARCH 31, 2022 AND DECEMBER 31, 2021

      (in thousands of CAD)

      March 31,


      December 31,


      2022


      2021


      $


      $

      Assets




      Current assets




         Cash and cash equivalents

      96,017


      104,296

         Trade and other receivables

      15,464


      13,659

         Prepaid expenses

      1,683


      1,811


      113,164


      119,766





      Property and equipment

      1,252


      1,137

      Right-of-use assets

      1,404


      1,568

      Intangible assets

      5,421


      5,819

      Goodwill

      7,007


      6,963

      Investment

      1,004


      —


      129,252


      135,253

      Liabilities




      Current liabilities




         Trade payable and accrued liabilities

      9,401


      9,534

         Unearned revenue

      584


      68

         Current portion of contingent consideration payable

      760


      718

         Current portion of long-term debt

      400


      400

         Current portion of lease liabilities

      482


      541


      11,627


      11,261





      Non-current portion of lease liabilities

      768


      911

      Non-current portion of long-term debt

      974


      1,074

      Non-current portion of contingent consideration payable

      1,378


      1,300

      Deferred income tax liability

      685


      766


      15,432


      15,312

      Commitments and contingencies








      Shareholders' equity




      Share capital

      458,983


      458,962

      Equity reserve

      4,080


      3,514

      Cumulative translation adjustment

      707


      347

      Deficit

      (349,950)


      (342,882)


      113,820


      119,941


      129,252


      135,253

      DIALOGUE HEALTH TECHNOLOGIES INC.
      INTERIM CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
      FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021

      (in thousands of CAD)

      Three months ended
      March 31,


      2022


      2021


      $


      $

      Operating activities




      Net loss

      (7,068)


      (231,235)

      Items not affecting cash




         Change in fair value of the contingent consideration- eHH

      91


      —

         Income tax recovery

      (85)


      (105)

         Change in conversion feature on preferred shares

      —


      225,417

         Depreciation of property and equipment

      148


      109

         Amortization of right-of-use assets

      150


      148

         Net financing (income) expenses

      (25)


      254

         Amortization of intangible assets

      402


      330

         Share-based payments

      568


      97


      (5,819)


      (4,985)

      Net changes in non-cash operating working capital items




         Trade and other receivables

      (1,804)


      (1,240)

         Prepaid expenses

      128


      (455)

         Trade and other payables

      (133)


      2,093

         Unearned revenue

      516


      499

      Interest paid

      (30)


      (14)

      Interest income

      68


      —


      (7,074)


      (4,102)





      Investing activities




         Investment

      (1,004)


      —

         Purchase of property and equipment

      (268)


      (187)

         Purchase of intangible assets

      —


      (18)

         Sale of asset held for sale

      —


      910

         Acquisition of Botfront

      —


      (292)


      (1,272)


      413

      Financing activities




         Issuance of shares

      —


      100,008

         Share issue costs

      —


      (9,371)

         Options exercised

      20


      392

         Repayment of liability related to asset held for sale

      —


      (430)

         Repayment of long-term debt

      (100)


      (100)

         Repayment of lease liabilities

      (213)


      (166)


      (293)


      90,333

      Effect of foreign currency translation

      360


      311

      Net (decrease) increase in cash and cash equivalents

      (8,279)


      86,955

      Cash and cash equivalents, beginning of the period

      104,296


      42,067

      Cash and cash equivalents, end of the period

      96,017


      129,022

      SOURCE Dialogue Health Technologies Inc.

      Investor relations: Jean Marc Ayas, Director, Investor Relations, [email protected]; Media Relations: Jean-Christophe de Le Rue, Director, Public and Government Relations, [email protected] / 613-806-0671

      Modal title

      Organization Profile

      Dialogue Health Technologies Inc.

        Also from this source

      • Dialogue Launches Health Panel to Help Canadians Understand and Act on Hidden Health Risks

      • Canadian employee well-being continues to decline as employers struggle to measure and improve outcomes

      • Dialogue launches Canada's first Canadian Medical Second Opinion program

      Contact PR Newswire

      • 866-245-2317
        from 7:30 AM - 6:30 PM ET
      • Become a Client
      • Request a Demo
      • Editorial Bureaus
      • Partnerships
      • General Enquiries
      • Media

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • Investor Relations

      About

      • About PR Newswire
      • About Cision
      • Careers
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • Platform Login
      • Privacy Policy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact Cision

      Products

      About

      My Services
      • All News Releases
      • Platform
      • Next Gen Communications Cloud
      • Cision Communications Cloud
      • my CNW
      877-269-7890
      from 8 AM - 10 PM ET
      • Terms of Use
      • Information Security Policy
      • Site Map
      • Cookie Settings
      • Accessibility Statement
      Copyright © 2026 CNW Group Ltd. All Rights Reserved. A Cision company.